Semaglutide Market Growth & Demand Trends — GLP-1 Market Size 2018 to 2026
Key Takeaways
46×Market growth in 8 years — diabetes to metabolic platform
<1%GLP-1 penetration in India despite 142M+ diabetics
14+Generic semaglutide brands launched in India by 2026
−48%Wegovy price cut in April 2026 triggered by generic competition
India Pricing Reality
Despite the global market explosion, India has seen a parallel generic wave — 14+ brands competing on the same molecule, driving prices from ₹5,660/month (Wegovy) down to ₹1,295/month (economy generics) — a 4× difference for the same active ingredient.
Compare all Semaglutide brands in India →